4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-011873
Director acquired 341 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Young Caroline · Director
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-13 | Other acquisition : show line 1 in the form 10b5-1 | +25 | $1.52 | $38 | 26,726 | D |
| 2024-06-14 | Other acquisition : show line 2 in the form 10b5-1 | +48 | $1.50 | $72 | 26,774 | D |
| 2024-06-17 | Other acquisition : show line 3 in the form 10b5-1 | +41 | $1.49 | $61 | 26,815 | D |
| 2024-06-18 | Other acquisition : show line 4 in the form 10b5-1 | +41 | $1.57 | $64 | 26,856 | D |
| 2024-06-20 | Other acquisition : show line 5 in the form 10b5-1 | +41 | $1.53 | $63 | 26,897 | D |
| 2024-06-21 | Other acquisition : show line 6 in the form 10b5-1 | +41 | $1.49 | $61 | 26,938 | D |
| 2024-06-24 | Other acquisition : show line 7 in the form 10b5-1 | +21 | $1.59 | $33 | 26,959 | D |
| 2024-06-25 | Other acquisition : show line 8 in the form 10b5-1 | +21 | $1.54 | $32 | 26,980 | D |
Loading xslF345X05/marketforms-66487.xml…